Last Updated on January 29, 2026 by Daily News Staff Social media often serves up disturbing images but you can minimize your ...
Put rules at the capability boundary: Use policy engines, identity systems, and tool permissions to determine what the agent ...
Add articles to your saved list and come back to them anytime. South Australian Premier Peter Malinauskas says he does not support the Adelaide Festival board’s offer to add Palestinian-Australian ...
In December 2025, J.P. Morgan upgraded Recursion Pharmaceuticals after REC-4881 showed rapid, durable polyp burden reductions and a favorable safety profile in familial adenomatous polyposis patients, ...
Section 1. Purpose. From the founding of our Republic, scientific discovery and technological innovation have driven American progress and prosperity. Today, America is in a race for global technology ...
Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min New Opportunity Zones criteria ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q2 2025 Earnings Call Transcript August 5, 2025 Recursion Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.41187 EPS, ...
Many commercial real estate developers and investors have been anxiously waiting to see what the second iteration of the opportunity zone tax incentive program would look like, and now they have their ...
– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results